Xenon Pharmaceuticals Inc. business relationships
Companies named in Xenon Pharmaceuticals Inc.’s 10-K filed 2026-02-26, and public companies whose annual reports name Xenon Pharmaceuticals Inc.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 5.4 / 10
- AI naming
- 72 / 100 Top 1% in its category
- Agent readiness
- 5 / 100
- AI adoption
- 0 / 100
Named in Xenon Pharmaceuticals Inc.’s annual report 1
“...llaborators' clinical product candidates, which include azetukalner and NBI-921355 (being developed by our collaborator Neurocrine Biosciences), along with product candidates we expect to enter clinical development, which include our pre-clinical compounds, are in varying stages of development and w...” SEC filing
Companies whose annual reports name Xenon Pharmaceuticals Inc. 1
“NBI‑921355 was in-licensed from Xenon Pharmaceuticals Inc. in 2019, and we retain global rights.” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.